These conclusions are consistent with the phenomenon observed in the previous study,14 and further complement the results of experiments in vivo, providing more valuable evidence for the idea that IGFL2‐AS1 may be an oncogene in CRC. The gene discussed is IGFL2; the disease is colorectal carcinoma.